ArticleAmerican journal of cancer research2019

Combination of enzastaurin and ATRA exerts dose-dependent dual effects on ATRA-resistant acute promyelocytic leukemia cells.

Cui Liang et al.PubMed ↗Full text ↗

No numbers read from the abstract.